Analysis of total human immunodeficiency virus (HIV)-specific CD4+ and CD8+ T-cell responses:: Relationship to viral load in untreated HIV infection

被引:588
作者
Betts, MR
Ambrozak, DR
Douek, DC
Bonhoeffer, S
Brenchley, JM
Casazza, JP
Koup, RA
Picker, LJ
机构
[1] Oregon Hlth & Sci Univ, Vaccine & Gene Therapy Inst, Portland, OR 97201 USA
[2] Swiss Fed Inst Technol, CH-8092 Zurich, Switzerland
[3] Univ Texas, SW Med Ctr, Dept Internal Med, Dallas, TX 75390 USA
关键词
D O I
10.1128/JVI.75.24.11983-11991.2001
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Human immunodeficiency virus (HIV)-specific T-cell responses are thought to play a key role in viral load decline during primary infection and in determining the subsequent viral load set point. The requirements for this effect are unknown, partly because comprehensive analysis of total HIV-specific CD4(+) and CD8(+) T-cell responses to all HIV-encoded epitopes has not been accomplished. To assess these responses, we used cytokine How cytometry and overlapping peptide pools encompassing all products of the HIV-1 genome to study total HIV-specific T-cell responses in 23 highly active antiretroviral therapy naive HIV-infected patients. HIV-specific CD8(+) T-cell responses were detectable in all patients, ranging between 1.6 and 18.4% of total CD8(+) T cells. HIV-specific CD4(+) T-cell responses were present in 21 of 23 patients, although the responses were lower (0.2 to 2.94%). Contrary to previous reports, a positive correlation was identified between the plasma viral load and the total HIV-, Env-, and Nef-specific CD8(+) T-cell frequency. No correlation was found either between viral load and total or Gag-specific CD4(+) T-cell response or between the frequency of HIV-specific CD4(+) and CD8(+) T cells. These results suggest that overall frequencies of HIV-specific T cells are not the sole determinant of immune-mediated protection in HIV-infection.
引用
收藏
页码:11983 / 11991
页数:9
相关论文
共 47 条
  • [1] Tat-specific cytotoxic T lymphocytes select for SIV escape variants during resolution of primary viraemia
    Allen, TM
    O'Connor, DH
    Jing, PC
    Dzuris, JL
    Mothé, BR
    Vogel, TU
    Dunphy, E
    Liebl, ME
    Emerson, C
    Wilson, N
    Kunstman, KJ
    Wang, XC
    Allison, DB
    Hughes, AL
    Desrosiers, RC
    Altman, JD
    Wolinsky, SM
    Sette, A
    Watkins, DI
    [J]. NATURE, 2000, 407 (6802) : 386 - 390
  • [2] Cellular immune responses and viral diversity in individuals treated during acute and early HIV-1 infection
    Altfeld, M
    Rosenberg, ES
    Shankarappa, R
    Mukherjee, JS
    Hecht, FM
    Eldridge, RL
    Addo, MM
    Poon, SH
    Phillips, MN
    Robbins, GK
    Sax, PE
    Boswell, S
    Kahn, JO
    Brander, C
    Goulder, PJR
    Levy, JA
    Mullins, JI
    Walker, BD
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2001, 193 (02) : 169 - 180
  • [3] Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine
    Amara, RR
    Villinger, F
    Altman, JD
    Lydy, SL
    O'Neil, SP
    Staprans, SI
    Montefiori, DC
    Xu, Y
    Herndon, JG
    Wyatt, LS
    Candido, MA
    Kozyr, NL
    Earl, PL
    Smith, JM
    Ma, HL
    Grimm, BD
    Hulsey, ML
    Miller, J
    McClure, HM
    McNicholl, JM
    Moss, B
    Robinson, HL
    [J]. SCIENCE, 2001, 292 (5514) : 69 - 74
  • [4] HIV-specific CD8+ T cells produce antiviral cytokines but are impaired in cytolytic function
    Appay, V
    Nixon, DF
    Donahoe, SM
    Gillespie, GMA
    Dong, T
    King, A
    Ogg, GS
    Spiegel, HML
    Conlon, C
    Spina, CA
    Havlir, DV
    Richman, DD
    Waters, A
    Easterbrook, P
    McMichael, AJ
    Rowland-Jones, SL
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2000, 192 (01) : 63 - 75
  • [5] Control of viremia and prevention of clinical AIDS in rhesus monkeys by cytokine-augmented DNA vaccination
    Barouch, DH
    Santra, S
    Schmitz, JE
    Kuroda, MJ
    Fu, TM
    Wagner, W
    Bilska, M
    Craiu, A
    Zheng, XX
    Krivulka, GR
    Beaudry, K
    Lifton, MA
    Nickerson, CE
    Trigona, WL
    Punt, K
    Freed, DC
    Guan, LM
    Dubey, S
    Casimiro, D
    Simon, A
    Davies, ME
    Chastain, M
    Strom, TB
    Gelman, RS
    Montefiori, DC
    Lewis, MG
    Emini, EA
    Shiver, JW
    Letvin, NL
    [J]. SCIENCE, 2000, 290 (5491) : 486 - 492
  • [6] Human immunodeficiency virus type 1-specific cytotoxic T lymphocyte activity is inversely correlated with HIV type 1 viral load in HIV type 1-infected long-term survivors
    Betts, MR
    Krowka, JF
    Kepler, TB
    Davidian, M
    Christopherson, C
    Kwok, S
    Louie, L
    Eron, J
    Sheppard, H
    Frelinger, JA
    [J]. AIDS RESEARCH AND HUMAN RETROVIRUSES, 1999, 15 (13) : 1219 - 1228
  • [7] Putative immunodominant human immunodeficiency virus-specific CD8+ T-Cell responses cannot be predicted by major histocompatibility complex class I haplotype
    Betts, MR
    Casazza, JP
    Patterson, BA
    Waldrop, S
    Trigona, W
    Fu, TM
    Kern, F
    Picker, LJ
    Koup, RA
    [J]. JOURNAL OF VIROLOGY, 2000, 74 (19) : 9144 - 9151
  • [8] Antiviral pressure exerted by HIV-1-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus
    Borrow, P
    Lewicki, H
    Wei, XP
    Horwitz, MS
    Peffer, N
    Meyers, H
    Nelson, JA
    Gairin, JE
    Hahn, BH
    Oldstone, MBA
    Shaw, GM
    [J]. NATURE MEDICINE, 1997, 3 (02) : 205 - 211
  • [9] Large clonal expansions of CD8(+) T cells in acute infectious mononucleosis
    Callan, MFC
    Steven, J
    Krausa, P
    Wilson, JDK
    Moss, PAH
    Gillespie, GM
    Bell, JI
    Rickinson, AB
    McMichael, AJ
    [J]. NATURE MEDICINE, 1996, 2 (08) : 906 - 911
  • [10] Decay kinetics of human immunodeficiency virus-specific CD8+ T cells in peripheral blood after initiation of highly active antiretroviral therapy
    Casazza, JP
    Betts, MR
    Picker, LJ
    Koup, RA
    [J]. JOURNAL OF VIROLOGY, 2001, 75 (14) : 6508 - 6516